Ally Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.51M Hold
12,000
0.44% 53
2025
Q4
$4.21M Hold
12,000
0.51% 43
2025
Q3
$3.88M Hold
12,000
0.48% 48
2025
Q2
$4.67M Hold
12,000
0.53% 36
2025
Q1
$5.22M Hold
12,000
0.59% 33
2024
Q4
$4.43M Buy
12,000
+8,000
+200% +$3.35M 0.54% 35
2024
Q3
$2.08M Buy
4,000
+2,000
+100% +$1.07M 0.25% 71
2024
Q2
$1.08M Sell
2,000
-5,000
-71% -$2.64M 0.13% 100
2024
Q1
$3.63M Hold
7,000
0.49% 53
2023
Q4
$3.3M Hold
7,000
0.43% 58
2023
Q3
$3.05M Buy
7,000
+4,000
+133% +$1.81M 0.45% 58
2023
Q2
$1.33M Buy
+3,000
New +$1.38M 0.19% 81
2021
Q3
Sell
-4,000
Closed -$1.53M 122
2021
Q2
$1.53M Hold
4,000
0.15% 105
2021
Q1
$1.44M Hold
4,000
0.14% 102
2020
Q4
$1.28M Hold
4,000
0.12% 105
2020
Q3
$1.07M Hold
4,000
0.17% 101
2020
Q2
$1.05M Hold
4,000
0.17% 96
2020
Q1
$908K Buy
+4,000
New +$1.09M 0.1% 106

Other funds holding ELV

Ally Financial's ELV Position: Q1 2026 in Review

Ally Financial held its Elevance Health (ELV) position steady in Q1 2026 at 12,000 shares worth $3.51M. The position accounts for 0.44% of the portfolio, ranked #53.

Ally Financial first reported a position in ELV in Q1 2020 and has held it in 18 quarters since. The position peaked at $5.22M in Q1 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Ally Financial held 12,000 shares of Elevance Health worth $3.51M as of Q1 2026.
  • Ally Financial left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.44% of Ally Financial's portfolio in Q1 2026, its #53 holding.
  • Ally Financial first reported a position in Elevance Health in Q1 2020 and has held it in 18 quarters since.
  • Ally Financial's Elevance Health position peaked at $5.22M in Q1 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Ally Financial's 13F filing for Q1 2026, filed 12 May 2026.